Michael Parini

Michael J. Parini serves as Chief Executive Officer of Spur Therapeutics and is also a member of the Company’s Board of Directors. Mr. Parini joined Spur (formerly Freeline Therapeutics) in March of 2021 as the Company’s President and Chief Operating Officer and was named Chief Executive Officer in August 2021. Mr. Parini brings more than 20 years’ experience in the biopharmaceutical industry, most recently serving as Executive Vice President and Chief Administrative, Legal and Business Development Officer at Vertex Pharmaceuticals, Inc. from March 2020 until February 2021 and as Executive Vice President and Chief Legal and Administrative Officer from January 2016 to March 2020. Prior to joining Vertex, he spent more than a decade at Pfizer Inc., where he served in multiple leadership roles within the company's global legal team, including Senior Vice President and Associate General Counsel. Prior to joining Pfizer, Mr. Parini served as a healthcare attorney at Akin, Gump, Strauss, Hauer & Feld, L.L.P. in Washington, D.C., where he provided legal counsel on federal and state regulatory and policy issues. Mr. Parini is a member of the New York and District of Columbia bars. He received a Bachelor of Arts degree in American Government from Georgetown University and a Juris Doctor degree from Georgetown University Law Center.